IOL Chemicals plans ₹500 Cr investment for growth
after close1 source ↓written by the desknot a recommendation
- in three strategic
- ₹500 crore
- in the coming
- 30% revenue growth
IOL Chemicals and Pharmaceuticals is investing ₹500 crore in three strategic projects aimed at expanding Ibuprofen capacity, entering CDMO formulations, and establishing a specialty chemical facility. These initiatives are designed to enhance existing operations and create new revenue streams, potentially driving 30% revenue growth in the coming years.
This investment reflects the growing demand for backward-integrated APIs and customer-led manufacturing in the chemicals and pharmaceuticals sector, positioning IOL for stronger market relationships and increased profitability.
Not investment advice. For informational purposes only.